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Abstract
Background—Excessive gestational weight gain (EGWG) closely associates with postpartum 
obesity. However, the causal role of EGWG in postpartum obesity has not been experimentally 
verified. The objective of this study was to determine whether and how EGWG causes long-term 
postpartum obesity.
Methods—C57BL/6 mice were fed with high-fat diet during gestation (HFFDG) or control chow, 
then their body composition and energy metabolism were monitored after delivery.
Results—We found that HFFDG significantly increased gestational weight gain. After delivery, 
adiposity of HFFDG-treated mice (Preg-HF) quickly recovered to the levels of controls. However, 
three months after parturition, Preg-HF mice started to gain significantly more body fat even with 
regular chow. The increase of body fat of Preg-HF mice was progressive with aging and by 9 
months after delivery had increased 2-fold above the levels of controls. The expansion of white 
adipose tissue (WAT) of Preg-HF mice was manifested by hyperplasia in visceral fat and 
hypertrophy in subcutaneous fat. Preg-HF mice developed low energy expenditure and UCP1 
expression in interscapular brown adipose tissue (iBAT) in later life. Although blood estrogen 
concentrations were similar between Preg-HF and control mice, a significant decrease in estrogen 
receptor α (ERα) expression and hypermethylation of the ERα promoter was detected in the fat 
of Preg-HF mice nine months after delivery. Interestingly, hypermethylation of ERα promoter and 
low ERα expression were only detected in adipocyte progenitor cells in both iBAT and WAT of 
Preg-HF mice at the end of gestation.
Conclusions—These results demonstrate that HFFDG causes long-term postpartum obesity 
independent of early postpartum fat retention. This study also suggests that HFFDG adversely 
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programs long-term postpartum energy metabolism by epigenetically reducing estrogen signaling 
in both BAT and WAT.
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Pregnancy; obesity; gestational weight gain; brown adipose tissue
Introduction
Since 2014, women have overtaken men in obesity by 4% in U.S. 1, 2. CDC studies also have 
found that there was a significant increase in obesity among women aged 60 and older 1, 3. 
Gestation is a unique physiological process that most women go through during child-
bearing age. To ensure fetal nutrient supply and lactation, maternal metabolism goes through 
a series of adaptations. Among these adaptations, gaining maternal body fat during 
pregnancy is predominant 4. Gaining proper weight during pregnancy has immediate and 
long-term health implications for both offspring and mothers. Compelling clinical data 
indicate that excessive gestational weight gain (EGWG) independently predicts long-term 
(up to decades) postpartum maternal obesity 5–10. However, little information is available 
regarding whether and how EGWG causes long-term postpartum maternal obesity. 
Conflicting results from studies of postpartum weight retention even have led to the notion 
that long-term postpartum obesity is a continuation of pregnancy-associated weight gain or 
fat retention 5–12.
Although mice have a relative short pregnancy, gestation robustly increases maternal body 
fat mass 4. These results led us to use mice as an animal model to study the causal 
relationship between EGWG and long-term postpartum obesity. We fed pregnant C57BL/6 
mice with a high-fat (HF) diet and monitored maternal adiposity and energy metabolism. 
Our studies showed that HF feeding during gestation (HFFDG) of mice resembles most 
metabolic phenotypes of EGWG-associated long-term postpartum obesity in humans. Most 
importantly, the quick recovery of adiposity after delivery indicates that HFFDG-induced 
long-term postpartum obesity is independent of postpartum fat retention. Therefore, the 
current study indicates that HFFDG adversely reprograms postpartum maternal energy 
metabolism and lead to a higher incidence of obesity.
Material and Methods
Materials.
Glucose, insulin, T3, collagenase and Dulbecco’s modified Eagle’s medium (DMEM) were 
from Sigma-Aldrich (St. Louis, MO). Antibody against estrogen receptor α (ERα) and PE-
conjugated anti-Sca-1 or PDGFRα antibodies were from R&D System (Minneapolis, MN). 
The anti-UCP1 antibody, FITC-conjugated antibody against CD29 or CD34, and mouse 
estradiol ELISA kit were purchased from the Abcam (Cambridge, MA). Anti-GAPDH 
antibody was from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). NuPAGE gels, 
SuperScript III reverse transcriptase and oligo(dT)12–18 primers were from Invitrogen 
(Carlsbad, CA). The mouse diabetes multiplex assay kit was from Bio-Rad (Hercules, CA). 
HF diet (60 kCal% from fat, 20 kCal% from protein, 20 kCal% from carbohydrate, energy 
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density: 5.24 kCal/g, catalog number D12492) was from Research Diets, Inc (New 
Brunswick, NJ). Regular chow (17 kCal% from fat, 25 kCal% from protein, 58 kCal% from 
carbohydrate, energy density: 3.1 kCal/g, catalog number 7912) was from Harlan 
Laboratories (Madison, WI).
Experimental animals.
C57BL/6 mice were from the Jackson Laboratory (Bar Harbor, ME). Ten to 12-week-old 
nulliparous female mice were randomly selected for mating. Normal C57BL6 sires or 
vasectomized male mice were fed with regular chow. Pregnancy was determined by the 
presence of a vaginal plug and was assigned the embryonic day (E) 0.5. Female mice mated 
with vasectomized males were used as non-pregnant controls. The pregnant or non-pregnant 
mice were randomly assigned to feed with HF or chow. One group of non-pregnant mice 
were fed with HF diet for 20 days. Therefore, there were 4 groups of mice: 1) non-pregnant 
chow-fed (Non-Preg-C); 2) non-pregnant HF-fed (Non-Preg-HF); 3) pregnant and fed with 
chow (Preg) and 4) pregnant and fed with HF (Preg-HF). After delivery, all mice were fed 
with chow. Body composition was determined by Echo-MRI (Houston, TX). Glucose 
tolerance tests were performed 9 months after delivery after 6-hour fasting with i.p. injection 
of glucose (2 g/kg of body weight). Tissues samples were collected in the fed state at E18.5 
and 36-week after delivery. Experiments using mouse models were carried out under the 
Association for Assessment and Accreditation of Laboratory Animal Care guidelines with 
approval from the University of California San Diego Animal Care and Use Committee.
Fat morphology study:
Adipocyte areas of WAT were measured using ImageJ software (NIH, Bethesda, MA), with 
at least 9 images of the randomly chosen area of one H&E stained section 13. Adipocytes 
were outlined to measure the cross-section areas, excluding those that were too small or too 
large (<100 or >4,800 arbitrary units).
Precursor cell-derived adipocyte differentiation.
The precursor cells were isolated by fluorescence-activated cell sorting (FACS) of the 
stromal vascular fraction (SVF) of mouse iBAT or gonadal WAT (gWAT) 14, 15. Briefly, 
SVFs were resuspended in PBS and incubated with anti-CD34, Sca-1 and PDGFRα 
antibodies (iBAT) or anti-CD34, Sca-1 and CD29 antibodies (gWAT) for 30 min on ice. 
Sorted cells were proliferated in DMEM supplemented with 20% FBS and 2.5 ng/ml bFGF 
for 2 weeks. Precursor cells from iBAT were cultured in a differentiation medium (DMEM 
with 10% FBS, 20 nmol/l insulin and 1 nmol/l T3) for 3 days and then switched to induction 
medium (differentiation medium plus 0.125 mmol/l indometacin, 5 µmol/l dexamethasone 
and 0.5 mmol/l IBMX). Two days later, the cells were switched back to differentiation 
medium for 5 days 14. Differentiated cells were stained with oil red O. Precursor cells from 
gWAT were induced to differentiate into white adipocytes as previously described 16.
Indirect Calorimetry, Western blot, and real-time PCR assays.
Used the same procedures as we previously described 4, 13. Sequence of specific primers are 
in Table 1.
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Measurement of methylation of the ERα promoter.
The methylation status of specific CpG dinucleotides within the exon A and C of mouse 
ERα promoter was determined by sodium bisulfite modification and pyrosequencing 17. 
Genomic DNA sample (1 μg) was modified by sodium bisulfate with an EpiTect Bisulfite kit 
(Qiagen). Modified DNA was used as a template and DNA fractions crossing the CpG sites 
of mouse ERα promoter were amplified by PCR using two pairs of primers: exon A, 
forward 5’-TGGGTTATTTGTGTTTTGTAGGATAG-3” and reverse 5’-
CTTAAATCTAATACAACAAAACCATTC-3’; exon C, forward 5’-
TGTTAAGTGTTTTGTTTATTGGTTG-3’ and reverse 5’-
CCTCTTTCCAAAAATATTCCATAAATT-3’ 17. The methylation level at the CpG sites of 
ERα promoter was determined and quantified by pyrosequencing and PyroMark Q24 
software (Qiagen).
Statistical analysis.
Data are expressed as a mean ± standard error of the mean (SEM). Statistical analyses were 
performed using the Student t-test or two-way ANOVA, followed by Bonferroni post-tests 
using Prism software. Differences were considered significant at p<0.05.
Results
HFFGD induced EGWG and long-term postpartum maternal obesity.
Mice are altricial, and WAT is developed postnatally. Therefore, the measurement of body 
fat by Echo-MRI in a pregnant mouse represents essentially only maternal adiposity. During 
gestation, there were significant increases in body fat and body weight of Preg mice (Fig. 
1a&b). Comparing Preg-HF with Preg dams, there was significantly more body fat and body 
weight gained in Preg-HF mice from early to the end of gestation (Fig. 1a&b). Litter sizes 
were comparable among the groups of mice (data not shown). Interestingly, a large decrease 
in body fat during delivery was observed in both Preg and Preg-HF dams (Fig. 1a).
To focus on the effect of EGWG during pregnancy and avoid effects of lactation on maternal 
metabolism, regular chow was provided to all mice immediately after delivery and pups 
were removed to stop lactation. Soon after delivery, body weight and fat content of Preg-HF 
mice was restored to the levels of Preg and Non-Preg-C mice (Fig. 1a&b). However, three 
months later, Preg-HF mice started to gain significantly more body fat than the other three 
groups of control mice, and the differences were more pronounced with aging (Fig. 1a). 
Nine months after delivery, body fat content of Preg-HF mice was 2-times higher than all 
control mice (Fig. 1a&c). In addition, impaired glucose tolerance (Fig. 1d), and elevated 
blood FFA and TG concentrations (Supplemental Fig. 1a&b) were detected in Preg-HF mice 
9 months after delivery. Together, these results indicate that HFFDG induces not only 
EGWG but also long-term postpartum obesity and metabolic defects.
As expected, HF feeding of age-matched non-pregnant mice significantly increased their 
body fat (Fig. 1a). After switching back to regular chow, Non-Preg-HF mice gained similar 
amount of body fat as Non-Preg-C and Preg mice (Fig. 1a), indicating that brief HF feeding 
at pup-bearing age does not induce obesity in later life. In addition, there were no 
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differences in postpartum body fat content (Fig. 1a), body weight (Fig. 1b), and insulin 
sensitivity (Fig. 1d) between Preg and Non-Preg-C mice, indicating that single normal 
pregnancy itself does not alter postpartum maternal metabolism.
HFFDG induced long-term postpartum hyperplasia and hypertrophy of WAT in a depot-
specific manner.
Expansion of WAT mass is caused by increasing adipocyte number (hyperplasia) and/or 
adipocyte volume (hypertrophy). We analyzed the WATs from Preg-HF and control mice 9 
months after delivery. The average adipocyte area of gonadal WAT (gWAT) from Preg-HF 
mice was significantly smaller than that of Preg mice (Fig. 2a). Comparison of the frequency 
distribution of adipocyte area revealed that there were significantly more small adipocytes in 
gWAT of Preg-HF mice (Fig. 2b). In contrast, average adipocyte area of inguinal WAT 
(iWAT) of Preg-HF was significantly greater than that of other three groups (Fig. 2c), while 
high frequencies of remarkably large adipocytes were found in iWAT of Preg-HF mice (Fig. 
2d). These data indicate that the increase of visceral WAT of Preg-HF mice in later 
postpartum life is mainly due to small adipocytes, while the expansion of subcutaneous WAT 
is mainly caused by hypertrophy.
Increased body fat was observed in Preg-HF mice during pregnancy and in late life (Fig. 1a). 
To study if the postpartum obese phenotype of Preg-HF mice is an extension of HFFDG-
induced adiposity, we analyzed the WAT samples from dams at E18.5. Interestingly, average 
adipocyte areas of gWAT from Preg-HF and Non-Preg-HF were similarly increased 
compared with that of Non-Preg-C or Preg mice (Fig. 2e). Inguinal WAT was not analyzed 
because of the mix of the mammary gland during pregnancy. There were higher frequencies 
of large adipocytes in gWAT of Preg-HF and Non-Preg-HF mice at E18.5 (Fig. 2f). These 
results indicate that similar to Non-Preg-HF mice, HF feeding of pregnant mice increased 
body fat mainly via hypertrophy.
Most importantly, when comparing the differences in adipocyte area and frequency 
distribution of gWAT between Preg-HF and Preg mice at E18.5 (Fig. 2e) and 9-months after 
delivery (Fig. 2a), there was a marked transition from enlarged adipocytes to a larger number 
of small adipocytes in visceral WAT of Preg-HF mice during the development of obesity in 
later life. These studies further support the concept that EGWG programs long-term 
postpartum maternal metabolic defects and obesity rather than retention of excess fat gained 
during pregnancy.
HFFDG reduced long-term postpartum energy expenditure and thermogenesis.
Except for very rare cases of genetic mutations, obesity is primarily caused by chronic 
energy imbalance from a variety of environmental conditions. In this regard, measurements 
of whole-body energy metabolism of the mice 8 months after delivery showed a significantly 
lower energy expenditure rate in Preg-HF mice (Fig. 3a). However, food intake, locomotor 
activity (data not shown) and respiratory exchange ratio (RER) (Fig. 3b) were similar among 
the 4 groups of mice. Since non-shivering thermogenesis plays an important role in energy 
expenditure, we then analyzed iBAT and found that, although there was no change in tissue 
mass (Fig. 1c), Preg-HF mice had significantly fewer brown adipocytes but larger lipid 
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vacuoles (Fig. 3c&d). Our study also revealed that UCP1 expression levels at both protein 
(Fig. 3e) and mRNA levels (Fig. 3f) were significantly decreased in iBAT of Preg-HF mice. 
In addition, mRNA levels of Dio2, PPARα, PGC-1α, Cox5α, Zfb516, and Cidea, but not β3 
adrenoreceptor (Adrb3), PRDM16, C/EBPβ, and PPARγ, were remarkably decreased in 
iBAT from Preg-HF mice (Fig. 3f). Most importantly, during acute cold exposure, core body 
temperatures of Preg-HF mice decreased more than those of the controls (Fig. 3g). Together, 
these results indicate that there were significant decreases in energy expenditure and BAT-
derived thermogenesis in later life of Preg-HF mice.
HF feeding enhanced UCP1 expression and energy expenditure during pregnancy.
UCP1 expression and BAT activation are suppressed during gestation 18–21, which raise the 
question of whether HFFDG enhances the inhibitory effect of pregnancy on BAT 
thermogenesis, but then maintains this inhibitory effect in postpartum life. To address this 
question, we studied the effect of HFFDG on energy metabolism and BAT activation during 
pregnancy. Consistent with previous reports, we found a steady decrease of UCP1 
expression in iBAT during pregnancy (data not shown) and reduction of energy expenditure 
in Preg mice (Fig. 4a&b), which further supports the concept that decreased BAT activity 
contributes to the adaptive decrease of maternal energy expenditure. Surprisingly, in contrast 
to our hypothesis, UCP1 expression (Fig. 4c) and energy expenditure rates of Preg-HF mice 
were remarkably higher than those of chow-fed Preg mice (Fig. 4b). Locomotor activities 
were similar between Preg-HF and Preg mice (Fig. 4d). However, energy intakes of Preg-HF 
mice were significantly higher than Preg mice (Fig. 4e). Together, these results indicate that, 
instead of reducing UCP1 expression and energy expenditure, HFFDG enhances BAT 
activation and energy expenditure during pregnancy. Of note, induction of UCP1 expression 
by HF feeding has been well documented in rodent models 22–25.
Comparing energy metabolism and UCP1 expression in iBAT from Preg-HF with those of 
Preg mice at E18.5 or 9 months after delivery, our studies revealed a reversed development 
of energy metabolism of Preg-HF mice, from increased UCP1 expression and energy 
expenditure during pregnancy to decreased UCP1 expression and energy expenditure in the 
late postpartum period. This change in energy metabolism parallels the reduction in brown 
adipocyte number and UCP1 expression in iBAT of Preg-HF mice. Similar to white 
adipocytes, brown adipocytes are postmitotic. Brown adipocyte renewal and hyperplastic 
growth of BAT are dependent on brown adipocyte progenitors. To study what causes the 
reduction of brown adipocyte number and a postpartum decrease of UCP1 expression in 
iBAT in Preg-HF mice, we isolated precursor cells from the stromal vascular fraction of 
iBAT at E18.5 and induced them to differentiate into brown adipocytes 26, 27. As shown in 
figure 4f, fewer brown adipocytes were produced from iBAT of Preg-HF dams. These results 
suggest that an increase in UCP1 protein levels in iBAT of Preg-HF mice at E18.5 occurs 
through increased UCP1 expression in pre-existing brown adipocytes rather than recruitment 
of new adipocytes. Decreased brown precursor cell differentiation potency most likely 
contributes to decreased postpartum brown adipocyte number.
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HFFDG reduced estrogen singling in postpartum fat.
Estrogen plays an important role in energy metabolism through a variety of mechanisms 
including food intake and direct regulation of lipid metabolism in peripheral tissues 28–30. 
Estrogen deficiency, which occurs post-menopausal, induces fat accumulation and obesity 
31
. Using ovariectomized mice and estradiol reconstitution, our study confirmed that 
estrogen deficiency increases fat deposition and reduces UCP1 expression in iBAT in mice 
(Supplemental Fig. 2).
The main characteristic of estrogen deficiency-induced obesity is an expansion of visceral 
fat 28–30. Our preliminary studies showed that the increase of gWAT of Preg-HF mice had a 
trend to be greater than other WATs (Fig. 1c), which led us to speculate that estrogen is 
involved in the development of postpartum obesity of Preg-HF mice. However, there were 
no significant changes in food intake and activity in Preg-HF mice, which most likely 
exclude the involvement of the estrogen/CNS pathway. Our results also suggest that, if 
estrogen is involved, it is unlikely through a systemic estrogen deficiency but rather through 
its local effects, because blood estradiol concentrations were similar between Preg-HF and 
controls (data not shown).
There are 2 estrogen receptors: ERα and ERβ. The metabolic effects of estrogen are 
primarily mediated by ERα 28, 29, 32. We measured the protein levels of ERα in 
metabolically active tissues 9 months after delivery. Expression levels of ERα protein and 
mRNA were significantly reduced in both iBAT and WAT in Preg-HF mice (Fig. 3e, 5a&b). 
However, there were no changes of ERα in the liver, skeletal muscle, or hypothalamus (Fig. 
5b). Accordingly, mRNA levels of estrogen-responsive gene EBAG9 (estrogen receptor-
binding fragment-associated antigen 9)33 were significantly decreased in fat but showed no 
change in liver, skeletal muscle, or hypothalamus of Preg-HF (Supplemental Figure 3). 
These results suggest that estrogen/ERα signaling was impaired in adipose tissues of Preg-
HF mice.
Maternal HF feeding increased methylation of the ERα promoters in adipocyte progenitors.
Reduction of ERα mRNA in WAT and BAT of Preg-HF mice suggests that the inhibition of 
ERα expression is likely at the transcriptional level. Methylation of ERα promoter 
suppresses ERα expression 17, 34–38. For the fat samples collected 9-months after delivery, 
the methylation levels of exons A and C within the mouse ERα promoter 39 were 
significantly increased in iWAT, gWAT, and iBAT (Fig. 5c). However, for the fat samples 
collected at E18.5, similar to ERα protein levels, there was no significant change in DNA 
methylation of the ERα promoters of Preg-HF mice (data not shown). These results indicate 
that increased methylation of the ERα promoters may mediate HFFDG-programmed lower 
ERα expression in adipose tissue in later life. These results also raise a question about how 
HFFDG programs such long-term effects on ERα gene expression in fat.
DNA methylation is stable and heritable during mitotic division and even differentiation 
processes. There is a renewal process in adipose tissue, through which progenitor-derived 
new adipocytes replace older mature adipocytes. Therefore, if adipocyte precursor cells were 
epigenetically programmed by HFFDG, increased DNA methylation at the ERα promoters 
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of the progenitor cells could be passed to the renewed mature adipocytes. Therefore, we 
isolated adipocyte progenitors from the dams’ gWAT (CD29+:CD34+:Sca-1+) and iBAT 
(PDGFRα +:CD34+:Sca-1+) at E18.5 using FACS 40, 41. We found that the methylation 
levels at the ERα promoters were significantly increased in both white and brown APs from 
Preg-HF mice (Fig.5d). Furthermore, after in vitro differentiation using sorted APs, 
hypermethylation at the ERα promoter regions was maintained (data not shown).
Discussion
To the best of our knowledge, this is the first experimental observation showing that HFFDG 
adversely programs lower rates of postpartum maternal energy expenditure and greater 
obesity, both independent of postpartum weight retention. This study also demonstrates that 
pregnancy opens a vulnerable window to resetting of maternal energy metabolism. As with 
fetal programming, which refers to the life-long effects of maternal nutrition on offspring’ 
health, we identify the process of HFFDG-induced long-term postpartum obesity and 
metabolic defects as maternal programming.
EGWG increases the risk of long-term postpartum obesity. However, it still is debatable 
whether EGWG causes the development of postpartum metabolic defects and obesity, 
especially when EGWG is complicated with postpartum fat retention. Using a HFFDG 
approach, our study revealed that excessive maternal energy intake significantly increased 
WAT weight gain, but this did not occur in other tissues (Supplemental Figure 4), which is a 
key characteristic in human EGWG 42. Similar to humans 5–10, female mice who received 
HFFDG spontaneously developed obesity several months after delivery. Most importantly, 
our study demonstrates that soon after delivery, adiposity of Preg-HF mice recovers to the 
same levels as controls. Therefore, these data demonstrate that HFFDG-induced postpartum 
obesity is not an extension of pregnancy-induced fat gain and postpartum fat retention in 
mice. We recognize that mouse gestation is relatively short and equals to the first and second 
trimester of human pregnancy. Therefore, HF feeding-induced EGWG in mice resembles the 
metabolic phenotypes in the early gestation in humans. However, women with EGWG 
during the first trimester have a much higher risk of developing long-term postpartum 
metabolic defects than mothers who experienced EGWG in the second and third trimester 8. 
Therefore, despite the short gestation, HFFDG of the mouse provides a useful animal model 
to study EGWG-programmed long-term postpartum obesity. We also realize that the HF diet 
used in this study has 60% calories from fat, which is considered an unphysiological diet. 
The main reason for using this HF diet is to produce the obese phenotype in the short 
pregnancy period in female mice, who are more resistant than male mice to diet-induced 
obesity 43, 44. More studies are required to determine whether other HF diets with lower fat 
content can reproduce similar EGWG and postpartum obesity phenotypes. In addition, the 
current study does not allow us to precisely distinguish the causal roles of caloric intake 
versus dietary fat (especially fatty acids) composition of the HF diet in HFFDG-induced 
postpartum obesity.
The high concurrence of pre-pregnant obesity and postpartum weight retention in women 
who experience EGWG complicates understanding about whether and how EGWG alters 
long-term postpartum energy metabolism. By controlling energy intake during gestation, our 
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current study allowed us to focus on the effect of HFFDG alone. Our results indicate that 
without pre-pregnant obesity and postpartum fat retention, HFFDG can program lower rates 
of maternal energy expenditure and induce late postpartum obesity. The steady increase of 
adiposity of Preg-HF mice without any diet challenge further reveals the large degree of 
HFFDG-impaired postpartum energy metabolism. Our study also does not support the 
notion that EGWG-associated long-term postpartum obesity is a continuation of pregnancy-
induced fat expansion and retention. Of note, removal pups after birth prevented us from 
studying the role of lactation in HFFDG-programmed postpartum obesity. Eliminating other 
factors such as lactation further demonstrates the prominence and casual role of HFFDG in 
the development of postpartum metabolic defects in mice.
Accumulative energy imbalance plays an essential role in the development of obesity. 
Prolonged HF feeding alters eating behavior of female mice 45. Perhaps because of the 
relative short period of HF feeding, our results revealed that HFFDG showed no significant 
effect on food intake or locomotor activity of mice during the long-term postpartum period. 
Decreased energy expenditure rates of Preg-HF mice suggest that energy imbalance 
underlies HFFDG-programmed postpartum obesity. The thermogenic activity of brown 
adipocytes is inversely correlated with BMI, which indicates that brown adipocytes play a 
key role in energy metabolism and obesity 46–49. Our results showed that the expression 
levels of UCP1 and major mitochondrial markers were significantly reduced in iBAT of 
Preg-HF mice several months after delivery. In addition, these mice were cold-intolerant. 
Therefore, we postulate that decreased BAT thermogenesis might cause the reduction of 
energy expenditure in maternal programming. Interestingly, our study also showed that, in 
contrast to the inhibitory effect of gestation on thermogenesis, HFFDG robustly enhances 
UCP1 expression and energy expenditure in pregnant mice. Again, the conversion of HF-
increased energy expenditure rate during gestation to low energy expenditure rate in later 
life indicates that EGWG programs a long process of reducing of BAT activity. The dynamic 
changes in WAT morphology also suggest that HFFDG-programmed WAT expansion is not 
a simple adipocyte size enlargement. Both white and brown adipocytes are postmitotic. 
Adipocyte renewal rate and functional characteristics of renewed adipocytes play key roles 
in maintaining WAT and BAT functions. The changes in tissue morphology and function of 
WAT and BAT in Preg-HF mice later life prompt us to propose that HFFDG might 
reprogram postpartum adipocyte renewal. Therefore, further studies are required to elucidate 
the role of adipocyte renewal and metabolism of both WAT and BAT in maternal 
programming.
Estrogen plays an important role in maintaining energy homeostasis and fat tissue 
development 50. Our study revealed that WAT distribution, fat morphology, and UCP1 
expression of HFFDG-induced long-term postpartum obese mice were similar to estrogen 
deficient patients and ovariectomized mice. However, our data indicate that HFFDG impairs 
ERα-mediated estrogen signaling in fat but not through a systemic reduction of hormone 
concentration and CNS. Systemic or tissue-specific (e.g., hypothalamus or adipocyte), ERα 
gene knockouts lead to obesity and insulin resistance in mice 32, 50–53. In addition, estrogen 
inhibits the commitment of white adipocyte lineage and adipocyte differentiation of 
mesenchymal stem cells through ERα 54–57. Our study demonstrated that HFFDG reduces 
ERα expression by increasing methylation of its promoter in adipocyte precursor cells. 
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Although the current study did not provide any evidence showing how HFFDG selectively 
increases ERα promoter methylation, epigenetic modification of ERα expression in 
adipocyte precursor cells provides an underlying mechanism through which HFFDG 
programs long-term postpartum obesity. We postulate that through adipocyte precursor cell-
directed postpartum adipocyte renewal, hypermethylation of ERα promoter and low ERα 
expression gradually become dominant in adipose tissues at the later time point. Further 
studies are required to verify if hypermethylation of the ERα promoter and impaired 
estrogen signaling mediate HFFDG-programmed long-term postpartum metabolic defects 
and obesity.
In summary, by feeding C57BL/6 mice with a HF diet during pregnancy, our study 
demonstrates that HFFDG adversely programs long-term postpartum metabolic defects and 
obesity, but this does not occur through postpartum fat retention. This study also reveals that 
HFFDG-programmed long-term postpartum obesity may occur through adipocyte precursor 
cell-directed WAT adipogenesis and thermogenesis in BAT. Most importantly, our current 
study demonstrates that pregnancy opens a vulnerable window for resetting maternal 
metabolism. If HFFDG-programmed metabolic defects, i.e. maternal programming, can be 
verified in human subjects with EGWG, it will provide an explanation for how women have 
overtaken men in the obesity epidemic.
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Non-Preg-HF non-pregnant HF-fed mice
Preg pregnant mice and fed with chow
Preg-HF pregnant and fed with HF
UCP1 uncoupling protein 1
PPARγ peroxisome proliferator–activated receptor γ
PGC-1α PPARγ co-activator 1 α
RER respiratory exchange ratio
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Figure 1. HFFDG induced EGWG and long-term postpartum obesity.
Nulliparous C57BL/6 female mice (10–12 weeks old) were mated with healthy or 
vasectomized males. Pregnancy was determined by the presence of a vaginal plug and 
assigned as embryonic day (E) 0.5. HF diet was provided to some pregnant mice (Preg-HF) 
or mice without pregnancy for 20 days (equal to mouse gestation, Non-Preg-HF). After 
delivery, regular chow was provided to all mice and lactation were stopped by removing 
pups. Body composition was monitored at indicate gestational ages and weekly after 
delivery using Echo-MRI (a,b&e). Tissues were weighed at the end of the study at fed state 
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(c). Glucose tolerance tested (GTT, i.p.) was performed 9-month after delivery with 6 hours 
fasting (d). Data are presented as mean ± SEM; n=16 for body composition study (a, b&e), 
n=8 for GTT (d); *p<0.05 vs. Preg at the same time point; # p<0.05 vs. the same group 
(Preg) at E0.5.
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Figure 2. HFFDG programmed postpartum adiposity by inducing hyperplasia in visceral WAT 
and hypertrophy in subcutaneous WAT.
WATs were collected 9 months after delivery (a-d) or at E18.5 (e&f). Adipocyte area was 
measured by using ImageJ software with HE-stained tissue sections. Images (9 per section) 
were randomly selected. Data are presented as mean ± SEM; n=8; *p<0.05 vs. Preg, # 
p<0.05 vs. Non-Preg-C. au: arbitrary units.
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Figure 3. HFFDG reduced energy expenditure and BAT-mediated thermogenesis in late life of 
dams.
Eight months after delivery, energy expenditure rates (a, normalized by lean tissue mass) and 
RER (b) were studied by CLAMS. Adipocyte number (c) and tissue structure (d) of iBAT (9 
months after delivery) were analyzed by counting nuclei with HE-stained section using 
ImageJ software. Expression levels of UCP1 and key players of brown adipogenesis were 
measured by Western blotting (e) and real-time PCR (f). Core body temperature (g) was 
monitored with i.p. implanted eMitter when mice were exposed to 4 °C air. Data are 
presented as mean ± SEM (a,b,c,e&f), except core body temperature (g, mean); n=8–10; 
*p<0.05 vs. Preg.
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Figure 4. HF feeding reversed the inhibitory effect of gestation on energy expenditure and UCP1 
expression in dam’s iBAT.
C57BL/6 mice were fed with HF or regular chow during pregnancy or same duration 
without pregnancy. Energy expenditure rate (a&b) and locomotor activity (d) were measured 
using the CLAMS from E17.5 to E18.5. UCP1 protein levels of iBAT were compared 
between Preg and Preg-HF mice at E18.5 at room temperature (c). Food intakes were 
measured during CLAMS assay and normalized by energy density and body weight (e). The 
SVF from iBAT at E18.5 were differentiated into brown adipocytes and stained with oil red 
O (f). Data are presented as mean ± SEM; n=6–8, * or #p<0.05 vs. Non-Preg-C, **p<0.01 
vs. Preg.
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Figure 5. HFFDG increased ERα promotors methylation in adipocyte precursor cells and 
reduced ERα expression in WAT and iBAT in later life.
Expression of ERα at the protein (a) and mRNA (b) level was studied using tissue samples 
from mice 9 months after delivery. Methylation of CpG sites in the exon A and C of the 
ERα promoter was determined by using Pyrosequencing with tissue samples from mice 9 
months after delivery (c) and adipocyte precursor cells from gWAT, iWAT and iBAT at E18.5 
(d). N= 6, *p<0.05 vs. Preg. SM: skeletal muscle.
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Table 1.
Sequences for real-time PCR primers
Gene   Forward (5’ to 3’)   Reverse (5’ to 3’)
18S rRNA CGAAAGCATTTGCCAAGAAT AGTCGGCATCGTTTATGGTC
Ucp1 TAAGCCGGCTGAGATCTTGT GGCCTCTACGACTCAGTCCA
Dio2 GGAGCATCTTCACCCAGTTT CTGCGCTGTGTCTGGAAC
Pparα GGGCAGCTGACTGAGGAA TCCGAGGGCTCTGTCATC
Cox5α GTCCTTAGGAAGCCCATCG TTAAATGAATTGGGAATCTCCAC
Pgc-1α TGAAAGGGCCAAACAGAGAG GTAAATCACACGGCGCTCTT
Cidea AGGCCAGTTGTGATGACTAAGAC AAACCATGACCGAAGTAGCC
Prdm16 CGTGGAGAGGAGTGTCTTCAG ACAGGCAGGCTAAGAACCAG
Pparγ CTGTGTCAACCATGGTAATTTCTT TGCTGTTATGGGTGAAACTCTG
C/ebpβ CACGTCTGTTGCGTCAGTC TGATGCAATCCGGATCAA
Zfp516 TCTGCTTCACCTTCAGATGC GTGTGGCAGATGCAGCAA
Adrb3 TCC CGA AGA AGG GAA CTG T CCT TCC GTC GTC TTC TGT GT
Ebag9 GCAACAGTGTTCTCGTTCCTAA GGGCAAAGTTATTTGATCTCCA
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